← Evidence map

ArticleJournal of the American Chemical Society2026

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

Ji Hyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42358219